Created at 7:05 p.m. Oct, 28, 2024
Author: jollydolphin
Related Note: 1488765231664 1
Rationale for change

Replace underline with bolding as the underline interacts poorly with the γ character. The underlining went through the γ character which caused me to phosphorylate.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#AMBOSS::0OaeIk #AK_Step1_v12::#B&B::04_Biochem::04_Vitamins::03_Other_Vitamins #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#Physeo::05_Biochem::05_Metabolism::41_Vitamin_K_-_Nutrition #AK_Step1_v12::#SketchyBiochem::04_Vitamins/Minerals::02_Fat_Soluble::04_Vitamin_K #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#NBME::31 #AK_Step1_v12::#B&B::16_Neuro::03_Neurovascular_Disorders::06_Treatment_of_TIA/Stroke::Extra #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Coagulation_Cascade #AK_Step1_v12::#AMBOSS::F1agij #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::03_Heparin_vs_warfarin::*Warfarin #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step1_v12::#NBME::22 #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Pixorize::01_Biochemistry::01_Vitamins::20_Vitamin_K_Biochemistry #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Coagulation_Cascade #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::06_Vitamin_K_Clinical_Implications #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step1_v12::#AMBOSS::lQavw4